利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

93 条记录 (耗时 0.034 秒)

    DEVICE AND PROCESS FOR RECOGNIZING A CORRECT USE OF AN ALCOHOL MEASURING DEVICE
    51.
    发明申请
    DEVICE AND PROCESS FOR RECOGNIZING A CORRECT USE OF AN ALCOHOL MEASURING DEVICE 有权
    用于识别正确使用酒精测量装置的装置和方法

    公开(公告)号：US20100251804A1

    公开(公告)日：2010-10-07

    申请号：US12546144

    申请日：2009-08-24

    申请人： Stefan Morley ,  Ulrich Köhler ,  Andreas Huth

    发明人： Stefan Morley ,  Ulrich Köhler ,  Andreas Huth

    IPC分类号： G01N33/497 ,  H04N7/18

    CPC分类号： G01N33/4972 ,  B60K28/063 ,  B60W2540/24

    摘要： A device and a process are provided for recognizing a correct use of an alcohol measuring device by a test subject. At least one alcohol measuring device is provided with a signal transmitter, an analysis and control unit and a camera unit. An image field of the camera unit is divided into an inner image field area and an outer image field area. The inner image field area detects at least the face area of the test subject. The camera unit records changes at a boundary between the inner image field area and the outer image field area. A signal sent by the signal transmitter in the inner image field area can be detected by the camera unit.

    摘要翻译： 提供了一种装置和方法，用于识别测试对象正确使用酒精测量装置。 至少一个酒精测量装置具有信号发射器，分析和控制单元以及相机单元。 相机单元的图像场被分成内部图像场区域和外部图像场域区域。 内部图像区域至少检测测试对象的面部区域。 相机单元在内部图像场区域和外部图像场区域之间的边界处记录变化。 信号发送器在内部图像区域中发送的信号可由相机单元检测。

    N-oxide anthranylamide derivatives and their use as medicaments
    52.
    发明授权
    N-oxide anthranylamide derivatives and their use as medicaments 失效
    N-氧化物苯甲酰胺衍生物及其作为药物的用途

    公开(公告)号：US07459470B2

    公开(公告)日：2008-12-02

    申请号：US10476755

    申请日：2002-05-03

    申请人： Alexander Ernst ,  Andreas Huth ,  Martin Krueger ,  Karl-Heniz Thierauch ,  Andreas Menrad ,  Martin Haberey

    发明人： Alexander Ernst ,  Andreas Huth ,  Martin Krueger ,  Karl-Heniz Thierauch ,  Andreas Menrad ,  Martin Haberey

    IPC分类号： A61K31/47 ,  C07D213/89

    CPC分类号： C07D213/89 ,  C07D401/12 ,  C07D405/12

    摘要： Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in the case of psoriasis, Kaposi's sarcoma, restenosis, endometriosis, Crohn's disease, Hodgkin's disease, leukemia; arthritis, such as rheumatoid arthritis, hemangioma, angiofibroma; eye diseases, such as diabetic retinopathy, neovascular glaucoma; renal diseases, such as glomerulonephritis, diabetic nephropathy, malignant nephrosclerosis, thrombic microangiopathic syndrome, transplant rejections and glomerulopathy; fibrotic diseases, such as cirrhosis of the liver, mesangial cell proliferative diseases, arteriosclerosis, injuries to nerve tissue, and inhibition of the reocclusion of vessels after balloon catheter treatment, in vascular prosthetics or after mechanical devices are used to keep vessels open, such as, e.g., stents, as immunosuppressive agents, as a support in scar-free healing, senile keratosis and contact dermatitis. The compounds according to the invention can also be used as VEGFR-3 inhibitors in the case of lymphangiogenesis.

    摘要翻译： 描述了取代的N-氧化邻氨基苯甲酰胺衍生物，其作为用于治疗由持续性血管生成触发的疾病的药剂的生产和用途被描述。 根据本发明的化合物可以用作银屑病，卡波西肉瘤，再狭窄，子宫内膜异位症，克罗恩病，霍奇金病，白血病，牛皮癣， 关节炎，如类风湿关节炎，血管瘤，血管纤维瘤; 眼睛疾病如糖尿病性视网膜病变，新生血管性青光眼; 肾脏疾病如肾小球性肾炎，糖尿病肾病，恶性肾硬化，血栓性微血管病综合征，移植排斥反应和肾小球病; 纤维化疾病，如肝硬化，肾小球膜细胞增生性疾病，动脉硬化，神经组织损伤，以及球囊导管治疗后血管再狭窄的抑制，血管修复术或机械装置用于保持血管开放的诸如 例如作为免疫抑制剂的支架，作为无疤痕愈合的支持，老年角化病和接触性皮炎。 在淋巴管生成的情况下，根据本发明的化合物也可以用作VEGFR-3抑制剂。

    VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
    56.
    发明申请
    VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines 失效
    VEGFR-2和VEGFR-3抑制性邻氨基苯甲酰胺吡啶

    公开(公告)号：US20050054654A1

    公开(公告)日：2005-03-10

    申请号：US10870491

    申请日：2004-06-18

    申请人： Andreas Huth ,  Ludwig Zorn ,  Martin Krueger ,  Stuart Ince ,  Karl Thierauch ,  Andreas Menrad ,  Martin Haberey ,  Holger Hess-Stumpp

    发明人： Andreas Huth ,  Ludwig Zorn ,  Martin Krueger ,  Stuart Ince ,  Karl Thierauch ,  Andreas Menrad ,  Martin Haberey ,  Holger Hess-Stumpp

    IPC分类号： C07D213/61 ,  C07D213/73 ,  C07D213/74 ,  C07D213/75 ,  C07D401/04 ,  C07D401/12 ,  C07D401/14 ,  C07D409/12 ,  C07D413/04 ,  C07D413/14 ,  C07D417/04 ,  C07D43/02 ,  A61K31/497 ,  A61K31/501 ,  A61K31/506 ,  C07D41/02

    CPC分类号： C07D213/61 ,  C07D213/73 ,  C07D213/74 ,  C07D213/75 ,  C07D401/04 ,  C07D401/12 ,  C07D401/14 ,  C07D409/12 ,  C07D413/04 ,  C07D413/14 ,  C07D417/04

    摘要： VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinamides, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, as well as intermediate products for the production of the compounds are described. The compounds according to the invention can be used as or in the case of tumor or metastasis growth, psoriasis, Kaposi's sarcoma, restenosis, such as, e.g., stent-induced restenosis, endometriosis, Crohn's disease, Hodgkin's disease, leukemia; arthritis, such as rheumatoid arthritis, hemangioma, angiofibroma; eye diseases, such as diabetic retinopathy, neovascular glaucoma; renal diseases, such as glomerulonephritis, diabetic nephropathy, malignant nephrosclerosis, thrombic microangiopathic syndrome, transplant rejections and glomerulopathy; fibrotic diseases, such as cirrhosis of the liver; mesangial cell proliferative diseases, arteriosclerosis, injuries to nerve tissue, and inhibition of the reocclusion of vessels after balloon catheter treatment, in vascular prosthetics or after mechanical devices are used to keep vessels open, such as, e.g., stents, as immunosuppressive agents, as a support in scar-free healing, senile keratosis and contact dermatitis. The compounds according to the invention can also be used as VEGFR-3 inhibitors in the case of lymphangiogenesis.

    摘要翻译： 描述了VEGFR-2和VEGFR-3抑制性邻氨基苯酰胺吡啶酰胺，其作为用于治疗由持续血管发生引起的疾病的药物的制备和用途，以及用于制备化合物的中间产物。 根据本发明的化合物可用于或在肿瘤或转移生长的情况下，牛皮癣，卡波西肉瘤，再狭窄，例如支架诱导的再狭窄，子宫内膜异位，克罗恩病，霍奇金病，白血病; 关节炎，如类风湿关节炎，血管瘤，血管纤维瘤; 眼睛疾病如糖尿病性视网膜病变，新生血管性青光眼; 肾脏疾病如肾小球性肾炎，糖尿病肾病，恶性肾硬化，血栓性微血管病综合征，移植排斥反应和肾小球病; 纤维化疾病，如肝硬化; 肾小球膜细胞增生性疾病，动脉硬化，神经组织损伤，以及球囊导管治疗后血管假体中或使用机械装置用于保持血管开放（例如，支架）作为免疫抑制剂的抑制，作为免疫抑制剂 无疤痕愈合，老年角化病和接触性皮炎的支持。 在淋巴管生成的情况下，根据本发明的化合物也可以用作VEGFR-3抑制剂。

    INTERMITTENT COATING OF MOVING SURFACES
    58.
    发明申请
    INTERMITTENT COATING OF MOVING SURFACES 有权
    移动表面的间隙涂层

    公开(公告)号：US20140227431A1

    公开(公告)日：2014-08-14

    申请号：US14342471

    申请日：2012-09-13

    申请人： Andreas Huth ,  Robert Sekler

    发明人： Andreas Huth ,  Robert Sekler

    IPC分类号： H01M4/04 ,  H01M4/139

    CPC分类号： H01M4/0416 ,  B05B1/1636 ,  B05B1/1645 ,  B05B1/1672 ,  B05B1/1681 ,  B05B1/28 ,  B05B11/3097 ,  B05C5/025 ,  B05C5/0254 ,  B05C5/0258 ,  B05C11/1034 ,  B05D1/26 ,  B05D1/265 ,  F16K11/074 ,  F16K11/083 ,  H01M4/0404 ,  H01M4/139

    摘要： A method of intermittently coating a moving surface with paste containing electrochemically active particles by a nozzle having a slot-shaped delivery opening includes supplying paste to the delivery opening from a paste reservoir via a transport channel and regulating paste supply to the delivery opening with a rotatably mounted control axle which enables the paste supply to the delivery opening in a first switching position and, in a second switching position, blocks the transport channel and disconnects a section of the transport channel extending as far as the delivery opening from the paste supply, wherein the rotatably mounted control axle comprises a passage via which the paste reservoir is in communicating connection with the delivery opening in the first switching position and the disconnected section of the transport channel is in communicating connection with the reduced pressure source in the second switching position.

    摘要翻译： 通过具有槽形输送口的喷嘴间歇地涂覆含有电化学活性粒子的糊剂的移动表面的方法包括通过输送通道从浆料储存器向输送口供给糊料，并且通过可转动的方式将浆料供给到输送口 其在第一切换位置中能够将浆料供应到输送口，并且在第二切换位置中阻塞输送通道并将从输送口延伸的输送通道的一部分从糊料供给部分断开，其中 可旋转地安装的控制轴包括通道，通过该通道，膏容器在第一切换位置与输送开口连通，输送通道的断开部分与第二切换位置中的减压源连通。